Aegera Therapeutics Acquires Clinical Stage Oncology Company and … - CNW Telbec (Communiqués de presse)

August 16th, 2007

Aegera Therapeutics Acquires Clinical Stage Oncology Company and …CNW Telbec (Communiqués de presse), Canada - Aug 8, 2007… a small molecule tyrosine kinase inhibitor in Phase 1 clinical trials for acute myelogenous leukemia and other myeloproliferative disorders. …

Read full story

Posted in Myeloproliferative Disorders | del.icio.us | Top Of Page |

Leave a Reply